Cardium Therapeutics, Inc.
Cardiology company merges with Aries Ventures
Published in Health Business Week, November 18th, 2005
Cardium Therapeutics and Aries Ventures will be headquartered in San Diego and will continue to trade under the Aries Ventures name and ticker symbol until the completion of its corporate name change to Cardium Therapeutics, Inc. In addition to the merger and equity financing, the company also announced the strategic acquisition of a portfolio of cardiovascular product candidates from Schering AG Germany.
"[This] announcement represents a substantial milestone for our stockholders, and sets the stage for us to pursue our business...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2005-11-18)
More Articles from Health Business Week
- BioInvent
Therapeutic antibodies developer implements a secured issue of shares worth SEK 160 million - Bioniche Life Sciences, Inc.
Bladder cancer drug developer signs agreement for private financing - Biophan Technologies, Inc.
MRI-focused medical device maker reports net loss of $6M - Biotechnology Industry Organization
Biotech group supports Santorum/Hart bill to amend tax law - Business & Finance
Dionex Corp. notified it meets all Nasdaq listing requirements - C. R. Bard, Inc.
Single-patient-use medical products maker reports 5% increase in sales - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
